The role of BRG1 as a mediator of T-bet activity in lung-resident CD8+ T cell memory formation
BRG1 作为 T-bet 活性介质在肺驻留 CD8 T 细胞记忆形成中的作用
基本信息
- 批准号:10528432
- 负责人:
- 金额:$ 0.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-01 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:ATP phosphohydrolaseAntibodiesAntibody FormationAntibody ResponseAntibody-mediated protectionAntigensBindingBinding SitesBrainCD8-Positive T-LymphocytesCD8B1 geneCatalytic DomainCell Differentiation processCell LineageCellsCellular ImmunityCessation of lifeChromatinChromatin Remodeling FactorClinicalComplexDataDevelopmentElderlyEnhancersEpigenetic ProcessEpitopesEventExposure toGene Expression ProfileGenerationsGenetic TranscriptionHomeHospitalizationImmune EvasionImmunityImmunizeImmunologic MemoryIndividualInfluenzaInfluenza A virusInstructionKnock-outLungMaintenanceMediator of activation proteinMembrane GlycoproteinsMemoryMentorshipMolecularMorbidity - disease rateMutationPatternPlayProcessRegulatory ElementResearchResearch TrainingResidual stateRespiratory Tract InfectionsRoleSMARCA4 geneScientistShapesSignal TransductionSpecific qualifier valueStructure of parenchyma of lungSucroseSurfaceT memory cellT-LymphocyteT-bet proteinTimeTissuesTo specifyTrainingVaccinatedVaccinesViralVulnerable PopulationsWritinganalogcareerchromatin remodelingdesignfluimprintin vivoinfluenza infectioninfluenza virus straininfluenza virus vaccineinsightmortalityneutralizing antibodyoverexpressionpathogenrational designrespiratory pathogenresponseseasonal influenzasecondary infectionskill acquisitionstatisticstechnique developmentthymocytetooltranscription factoruniversal influenza vaccinevaccine failure
项目摘要
Project Summary/Abstract
Respiratory infections account for millions of hospitalizations and deaths each year globally. Notably, seasonal
Influenza virus infections accounts for a significant fraction of these statistics, and attempts to vaccinate against
these strains have mixed efficacy. Current strategies to immunize against influenza involve eliciting antibody
responses against surface glycoproteins, but the high mutation rate of influenza allows for immune evasion
against antibodies. Therefore, the design and development of influenza vaccines that provide long-lived cellular
immunological memory and offers broad protection represents a major unmet clinical need. To this end, a
vaccine that elicits memory CD8+ T cells, which recognize viral epitopes that are conserved across diverse flu
strains, may be necessary for optimal protection. However, the cell-intrinsic molecular events involved in the
formation of memory CD8+ T cells in the lung are poorly characterized. Additionally, it has been shown that lung
tissue immunity wanes over time, resulting in a narrow window of protection against secondary infection. This
proposal seeks to investigate how modulation of chromatin states influences the differentiation of lung resident
memory (TRM) cells that are protective against influenza infection, with the hypothesis that the lineage-defining
transcription factors T-bet and EOMES tunes the activity of the SWI/SNF chromatin remodeling complex to
imprint chromatin states that promote TRM versus circulating memory (TCIRCM) cell fates. Three specific aims are
proposed to interrogate this hypothesis. The first aim will define the T-bet and EOMES-bound regulatory
elements that are permissive and/or instructive for lung TRM and TCIRCM cell differentiation. The second aim seeks
to define chromatin states in TCIRCM and TRM cells that are dependent on BRG1, a core ATPase subunit of the
SWI/SNF chromatin remodeling complex. Finally, the third aim will evaluate the importance of BRG1 in
establishing chromatin states that promoting or suppressing lung TRM formation in vivo. In summary, this proposal
seeks to provide insight into the molecular machinery that control the formation of lung TRM formation after flu
infection. Understanding the mechanisms governing this process will enhance our capacity to induce long-lived
protective cellular immunity in a vaccine setting against respiratory infections. This application details the
applicant’s training plan including research mentorship, advanced coursework, training in new techniques, and
development of skills in scientific professionalism, writing, and presentation of data. The research and training
outlined in this application will prepare the applicant to pursue a career in the conduct of academic research as
an independent scientist.
项目总结/摘要
呼吸道感染每年导致全球数百万人住院和死亡。特别是季节性的
流感病毒感染占这些统计数据的很大一部分,
这些菌株具有混合的功效。目前针对流感的免疫策略包括引发抗体
针对表面糖蛋白的免疫应答,但流感的高突变率允许免疫逃避
对抗抗体。因此,提供长寿命细胞免疫的流感疫苗的设计和开发,
免疫记忆并提供广泛的保护代表了主要的未满足的临床需求。为此,A
疫苗,激发记忆CD 8 + T细胞,识别在不同流感病毒中保守的病毒表位,
菌株,可能是必要的最佳保护。然而,参与细胞内的分子事件,
记忆性CD 8 + T细胞在肺中的形成特征不明显。此外,已经表明肺
随着时间的推移,组织免疫力减弱,导致对继发感染的保护窗口变窄。这
一项提案旨在研究染色质状态的调节如何影响肺居民的分化,
记忆(TRM)细胞对流感感染具有保护作用,假设谱系定义
转录因子T-bet和EOMES调节SWI/SNF染色质重塑复合物的活性,
印记染色质状态促进TRM与循环记忆(TCIRCM)细胞命运。三个具体目标是
他试图质疑这个假设。第一个目标将定义T-bet和EOMES约束的监管
允许和/或指导肺TRM和TCIRCM细胞分化的元件。第二个目标是
为了确定TCIRCM和TRM细胞中依赖于BRG 1的染色质状态,BRG 1是TIRCM和TRM细胞的核心ATP酶亚基。
SWI/SNF染色质重塑复合物。最后,第三个目标将评估BRG 1在以下方面的重要性:
在体内建立促进或抑制肺TRM形成的染色质状态。总而言之,这一提议
旨在提供对流感后控制肺TRM形成的分子机制的深入了解
感染了解这一过程的机制将提高我们诱导长寿的能力。
在针对呼吸道感染的疫苗设置中的保护性细胞免疫。此应用程序详细说明了
申请人的培训计划,包括研究指导,高级课程,新技术培训,以及
发展科学专业精神、写作和数据呈现方面的技能。研究和培训
概述在此应用程序将准备申请人追求的职业生涯中进行学术研究,
独立的科学家。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bryan McDonald其他文献
Bryan McDonald的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bryan McDonald', 18)}}的其他基金
Chromatin remodeling in CD8+ T cells and harnessing stromal-immune interactions for effective antitumor immunity
CD8 T 细胞中的染色质重塑和利用基质免疫相互作用实现有效的抗肿瘤免疫
- 批准号:
10530061 - 财政年份:2022
- 资助金额:
$ 0.97万 - 项目类别:
Chromatin remodeling in CD8+ T cells and harnessing stromal-immune interactions for effective antitumor immunity
CD8 T 细胞中的染色质重塑和利用基质免疫相互作用实现有效的抗肿瘤免疫
- 批准号:
10665772 - 财政年份:2022
- 资助金额:
$ 0.97万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 0.97万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 0.97万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 0.97万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 0.97万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 0.97万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 0.97万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 0.97万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 0.97万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 0.97万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 0.97万 - 项目类别:














{{item.name}}会员




